Spotting
 Timeline
 Travel Tip
 Trip
 Race
 Social
 Greeting
 Poll
 Img
 PNR
 Pic
 Blog
 News
 Conf TL
 RF Club
 Convention
 Monitor
 Topic
 Followed
 Rating
 Correct
 Wrong
 Stamp
 HJ
 Vote
 Pred
 @
 FM Alert
 FM Approval
 Pvt
News Super Search
 ↓ 
×
Member:
Posting Date From:
Posting Date To:
Category:
Zone:
Language:
IR Press Release:

Search
  Go  

Start RailFanning NOW, learn to live - before you run out of time - Varun

Full Site Search
  Full Site Search  
 
Fri Oct 23 14:52:37 IST
Home
Trains
ΣChains
Atlas
PNR
Forum
Topics
Gallery
News
FAQ
Trips/Spottings
Login
Advanced Search
<<prev entry    next entry>>
News Entry# 419293
Sep 23 (14:51) Coronavirus vaccine update | Mumbai's KEM Hospital starts trials of Covishield vaccine (www.moneycontrol.com)
*covid-19
0 Followers
757 views

News Entry# 419293  Blog Entry# 4723259   
  Past Edits
This is a new feature showing past edits to this News Post.
Last Updated : Sep 23, 2020 02:32 PM IST | Source: PTI
The hospital, located in Parel area, on Tuesday got the approval of the Maharashtra ethics committee for conducting the vaccine trials.
The civic-run King Edward Memorial (KEM) Hospital in Mumbai on Wednesday began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.
The hospital, located in Parel
...
more...
area, on Tuesday got the approval of the Maharashtra ethics committee for conducting the vaccine trials.
KEM Hospital Dean Dr Hemant Deshmukh told PTI that the hospital has started screening volunteers for the trials.
The medical facility will be conducting the trials on 100 volunteers, he said.
The city-based B Y L Nair Hospital, another facility run by the Brihanmumbai Municipal Corporation (BMC), has also received approval for conducting trials of the vaccine.
Both the KEM and Nair hospitals will be conducting the trials collectively on over 200 volunteers, sources said.
As part of the trials, volunteers who are found negative for coronavirus in both RT-PCR and antigen tests will be given the vaccine, they said.
Trials of the Oxford vaccine candidate are being conducted in Pune also.
The Pune-based Serum Institute of India (SII) has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, being developed by the University of Oxford, UK.
Go to Full Mobile site